These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2767107)

  • 21. Chemotherapy-induced palmer planter erythrodysesthesia.
    Bhasin S; Sunita ; Gupta DK; Kataria SP; Saluja S; Sharma M
    J Assoc Physicians India; 2005 Feb; 53():155-6. PubMed ID: 15847041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia.
    Burgdorf WH; Gilmore WA; Ganick RG
    Ann Intern Med; 1982 Jul; 97(1):61-2. PubMed ID: 7046555
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor.
    Kalaycio M; Pohlman B; Elson P; Lichtin A; Hussein M; Tripp B; Andresen S
    Am J Clin Oncol; 2001 Feb; 24(1):58-63. PubMed ID: 11232951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions.
    Kampmann KK; Graves T; Rogers SD
    Cancer; 1989 Jun; 63(12):2482-5. PubMed ID: 2655870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
    Sternberg DW; Aird W; Neuberg D; Thompson L; MacNeill K; Amrein P; Shulman LN
    Cancer; 2000 May; 88(9):2037-41. PubMed ID: 10813714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.
    Harousseau JL; Reiffers J; Hurteloup P; Milpied N; Guy H; Rigal-Huguet F; Facon T; Dufour P; Ifrah N
    J Clin Oncol; 1989 Jan; 7(1):45-9. PubMed ID: 2642539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Painful blistered hands and feet.
    Coyle C; Wenhold V
    Clin J Oncol Nurs; 2001; 5(5):230-2. PubMed ID: 11899771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
    Pigneux A; Harousseau JL; Witz F; Sauvezie M; Bene MC; Luquet I; Hunault-Berger M; Recher C; Lioure B; Himberlin C; Escoffre-Barbe M; Berthou C; Lissandre S; Fegueux N; Cahn JY; Jourdan E; Dreyfus F; Reiffers J; Milpied N; Ifrah N
    J Clin Oncol; 2010 Jun; 28(18):3028-34. PubMed ID: 20479424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
    Wu L; Li X; Su J; Chang C; He Q; Zhang X; Xu L; Song L; Pu Q
    Leuk Lymphoma; 2009 Sep; 50(9):1461-7. PubMed ID: 19672772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia.
    Crawford JH; Eikelboom JW; McQuillan A
    Eur J Haematol; 2002; 69(5-6):315-7. PubMed ID: 12460237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taxol-induced acral erythema.
    de Argila D; Dominguez JD; Iglesias L
    Dermatology; 1996; 192(4):377-8. PubMed ID: 8864381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study.
    Willemze R; Jager U; Jehn U; Stryckmans P; Bury J; Suciu S; Solbu G; Zittoun R; Burghouts J; Löwenberg B
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1721-5. PubMed ID: 3061827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia.
    Visani G; Petti MC; Cenacchi A; Manfroi S; Tosi P; Spadea A; Latagliata R; Amadori S; Mandelli F; Tura S
    Leuk Lymphoma; 1995 Nov; 19(5-6):447-51. PubMed ID: 8590845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of acute myeloblastic leukaemia with DAM regimen.
    Yunus AB; Sayeed MA; Barua A; Rahman J; Rashid MA
    Bangladesh Med Res Counc Bull; 1997 Dec; 23(3):82-6. PubMed ID: 9621477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clofarabine-induced acral erythema during the treatment of patients with myelodysplasia and acute leukemia: report of two cases.
    Chiao N; Bumgardner A; Duvic M
    Leuk Lymphoma; 2003 Aug; 44(8):1405-7. PubMed ID: 12952235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.
    Low M; Lee D; Coutsouvelis J; Patil S; Opat S; Walker P; Schwarer A; Salem H; Avery S; Spencer A; Wei A
    Intern Med J; 2013 Mar; 43(3):294-7. PubMed ID: 22757980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome.
    Bow EJ; Kilpatrick MG; Scott BA; Clinch JJ; Cheang MS
    Cancer; 1994 Jul; 74(1):52-60. PubMed ID: 8004583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation.
    Crider MK; Jansen J; Norins AL; McHale MS
    Arch Dermatol; 1986 Sep; 122(9):1023-7. PubMed ID: 3527075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.